Dexmedetomidine Plus Ropivacaine versus Ropivacaine Alone for Interscalene Brachial Plexus Block in Shoulder Surgery: Evidence from a Systematic Review and Meta-analysis
DOI:
https://doi.org/10.64531/7femvd90Keywords:
Dexmedetomidine, Ropivacaine, Interscalene brachial plexus block, Shoulder surgery, Meta-analysisAbstract
Introduction: Shoulder surgery is associated with significant postoperative pain that often hinders rehabilitation. Interscalene brachial plexus block (ISB) with ropivacaine provides effective analgesia, but its limited duration necessitates adjuvants. Dexmedetomidine, a selective α₂-adrenergic agonist, has been proposed to enhance block quality and prolong analgesia. Objective: To evaluate the efficacy and safety of adding perineural dexmedetomidine to ropivacaine for ISB in patients undergoing shoulder surgery. Methods: A systematic search of PubMed, Cochrane Library, and ScienceDirect was conducted up to [insert date]. Randomized controlled trials comparing ropivacaine with versus without perineural dexmedetomidine in adult patients receiving ISB for shoulder surgery were included. The primary outcome was postoperative pain at 8–12 hours. Secondary outcomes included block onset and duration, opioid consumption, and adverse events. Risk of bias was assessed with the Cochrane RoB 2 tool. Pooled results were analyzed using random-effects models. Results: Five RCTs involving 261 patients were included. Dexmedetomidine combined with ropivacaine significantly reduced 8–12 hour pain scores (MD −1.82, 95% CI −2.47 to −1.16; p < 0.00001), prolonged sensory and motor block, and reduced postoperative opioid consumption. Heterogeneity was moderate-to-high (I² = 83%), largely due to differences in dexmedetomidine doses and ropivacaine concentrations. Adverse events such as bradycardia and hypotension were more common at higher doses, but no major complications were reported. Discussion: Dexmedetomidine provided clinically meaningful analgesic benefits, exceeding the minimal clinically important difference, but required careful dosing to avoid cardiovascular side effects. Conclusion: Perineural dexmedetomidine enhances the efficacy of ropivacaine in ISB for shoulder surgery, offering superior analgesia and opioid-sparing effects. Further studies should refine optimal dosing and long-term outcomes.
References
1. El-Boghdadly K, Chin KJ, Chan VWS. Phrenic Nerve Palsy and Regional Anesthesia for Shoulder Surgery: Anatomical, Physiologic, and Clinical Considerations. Anesthesiology. 2017 July;127(1):173–91.
2. Abdallah FW, Brull R. Facilitatory effects of perineural dexmedetomidine on neuraxial and peripheral nerve block: a systematic review and meta-analysis. Br J Anaesth. 2013 June;110(6):915–25.
3. Sahu G, Meena D, Saini S, Aravindan A, Datta P. Comparison of two different volumes of ropivacaine used in nerve stimulator guided inter-scalene block for arthroscopic shoulder surgery – A randomized controlled trial. Anesth Essays Res. 2018;12(4):786.
4. Pöpping DM, Elia N, Marret E, Wenk M, Tramèr MR, Warner DS, et al. Clonidine as an Adjuvant to Local Anesthetics for Peripheral Nerve and Plexus Blocks: A Meta-analysis of Randomized Trials. Anesthesiology. 2009 Aug 1;111(2):406–15.
5. Vorobeichik L, Brull R, Abdallah FW. Evidence basis for using perineural dexmedetomidine to enhance the quality of brachial plexus nerve blocks: a systematic review and meta-analysis of randomized controlled trials. Br J Anaesth. 2017 Feb;118(2):167–81.
6. Brummett CM, Hong EK, Janda AM, Amodeo FS, Lydic R. Perineural Dexmedetomidine Added to Ropivacaine for Sciatic Nerve Block in Rats Prolongs the Duration of Analgesia by Blocking the Hyperpolarization-activated Cation Current. Anesthesiology. 2011 Oct 1;115(4):836–43.
7. Chen Z, Liu Z, Feng C, Jin Y, Zhao X. Dexmedetomidine as an Adjuvant in Peripheral Nerve Block. Drug Des Devel Ther. 2023 May;Volume 17:1463–84.
8. Weerink MAS, Struys MMRF, Hannivoort LN, Barends CRM, Absalom AR, Colin P. Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine. Clin Pharmacokinet. 2017 Aug;56(8):893–913.
9. Albrecht E, Vorobeichik L, Jacot-Guillarmod A, Fournier N, Abdallah FW. Dexamethasone Is Superior to Dexmedetomidine as a Perineural Adjunct for Supraclavicular Brachial Plexus Block: Systematic Review and Indirect Meta-analysis. Anesth Analg. 2019 Mar;128(3):543–54.
10. Cai H, Fan X, Feng P, Wang X, Xie Y. Optimal dose of perineural dexmedetomidine to prolong analgesia after brachial plexus blockade: a systematic review and Meta-analysis of 57 randomized clinical trials. BMC Anesthesiol. 2021 Dec;21(1):233.
11. Lee JJ, Kim D, Hwang J, Song D, Lee HN, Jang JS, et al. Dexmedetomidine combined with suprascapular nerve block and axillary nerve block has a synergistic effect on relieving postoperative pain after arthroscopic rotator cuff repair. Knee Surg Sports Traumatol Arthrosc. 2021 Dec;29(12):4022–31.
12. Hwang JT, Jang JS, Lee JJ, Song DK, Lee HN, Kim DY, et al. Dexmedetomidine combined with interscalene brachial plexus block has a synergistic effect on relieving postoperative pain after arthroscopic rotator cuff repair. Knee Surg Sports Traumatol Arthrosc. 2020 July;28(7):2343–53.
13. Rashmi H, Komala H. Effect of dexmedetomidine as an adjuvant to 0.75% ropivacaine in interscalene brachial plexus block using nerve stimulator: A prospective, randomized double-blind study. Anesth Essays Res. 2017;11(1):134.
14. Abdallah FW, Dwyer T, Chan VWS, Niazi AU, Ogilvie-Harris DJ, Oldfield S, et al. IV and Perineural Dexmedetomidine Similarly Prolong the Duration of Analgesia after Interscalene Brachial Plexus Block: A Randomized, Three-arm, Triple-masked, Placebo-controlled Trial. Anesthesiology. 2016 Mar;124(3):683–95.
15. Albrecht E, Vorobeichik L, Jacot-Guillarmod A, Fournier N, Abdallah FW. Dexamethasone Is Superior to Dexmedetomidine as a Perineural Adjunct for Supraclavicular Brachial Plexus Block: Systematic Review and Indirect Meta-analysis. Anesth Analg. 2019;128:543–54.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Ilsyafitri Bonita, Zulkifli, Rizky Dani (Author)

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

